We tested the adoptive transfer of bone marrow derived DCs from B6NQ into Ncf1* / * mutant hosts bearing B16F10 tumors and observed a modest result showing a greater tumor burden that did not reach statistical significance ( Figure 4 I). 3.9.
← all excerpts
Anti-Tumoral Treatment with Thioredoxin Reductase 1 Inhibitor Auranofin Fosters Regulatory T Cell and B16F10 Expansion in Mice.
1
—
—